UBS Group
SONM icon

UBS Group’s DNA X Inc SONM Stock Holding History

UBS Group’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Sell
2,304
-33,915
-94% -$150K ﹤0.01% 8476
2026
Q1 		$146K Buy
36,219
+27,537
+317% +$130K ﹤0.01% 6803
2025
Q4 		$27.3K Buy
8,682
+8,474
+4,074% +$76K ﹤0.01% 7584
2025
Q3 		$2.26K Sell
208
-2,807
-93% -$32.5K ﹤0.01% 9195
2025
Q2 		$66.2K Buy
3,015
+2,029
+206% +$50K ﹤0.01% 7550
2025
Q1 		$38K Buy
+986
New +$47.1K ﹤0.01% 7784
2024
Q4 		– Hold
0
– – – 9850
2024
Q3 		– Hold
0
– – – 9403
2024
Q2 		– Sell
-28
Closed -$3.04K – 10042
2024
Q1 		$3.04K Buy
+28
New +$3.44K ﹤0.01% 7782
2023
Q4 		– Sell
-1
Closed -$66 – 9842
2023
Q3 		$66 Buy
+1
New +$140 ﹤0.01% 8964
2023
Q1 		– Sell
-257
Closed -$19.9K – 10313
2022
Q4 		$19.9K Buy
+257
New +$21.1K ﹤0.01% 7650
2021
Q4 		– Sell
-9
Closed -$4K – 10664
2021
Q3 		$4K Buy
+9
New +$6.83K ﹤0.01% 8679
2021
Q2 		– Sell
-6
Closed -$9K – 9785
2021
Q1 		$9K Buy
+6
New +$10.6K ﹤0.01% 8022
2020
Q4 		– Sell
-10
Closed -$15K – 8721
2020
Q3 		$15K Hold
10
– – ﹤0.01% 6533
2020
Q2 		$15K Buy
10
+7
+233% +$11.2K ﹤0.01% 6748
2020
Q1 		$4K Sell
3
-7
-70% -$33.5K ﹤0.01% 7414
2019
Q4 		$68K Buy
10
+8
+400% +$39.5K ﹤0.01% 6197
2019
Q3 		$8K Buy
2
+1
+100% +$15.3K ﹤0.01% 7291
2019
Q2 		$28K Buy
+1
New +$25.4K ﹤0.01% 6388

Other funds holding SONM

CWM
C2C Wealth Management Scottsdale, Arizona $128M AUM 22.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

UBS Group's SONM Position: Q2 2026 in Review

UBS Group reduced its DNA X Inc (SONM) stake by 94% in Q2 2026, selling an estimated $150K and leaving 2,304 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #8476.

UBS Group first reported a position in SONM in Q2 2019 and has held it in 17 quarters since. The position peaked at $146K in Q1 2026. 9 funds tracked by Wall St. Rank hold SONM as of Q2 2026.

  • UBS Group held 2,304 shares of DNA X Inc worth $11.9K as of Q2 2026.
  • UBS Group sold 33,915 DNA X Inc shares in Q2 2026, an estimated $150K.
  • DNA X Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8476 holding.
  • UBS Group first reported a position in DNA X Inc in Q2 2019 and has held it in 17 quarters since.
  • UBS Group's DNA X Inc position peaked at $146K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.